25 October 2027 | Workshop Day
26-27 October 2027 | Conference & Exhibition
Lyon Convention Centre, France

R&D + Strategic Partnering For The
Global Vaccine Industry

Apply to sponsor/exhibit/speak

REGISTER NOW

WHY ATTEND?

Europe's Largest Vaccine Event

From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.

2,000+

Attendees

280

Speakers

150+

Exhibitors

3

Days

2,000+

1 to 1 Partnering Meetings

18,000+

Networking Connections

Conference

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more

APPLY TO SPEAK

Exhibition

150+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions

APPLY TO SPONSOR/EXHIBIT

Networking

Networking is at the heart of World Vaccine Congress Europe. Our congress allows you to connect directly with thousands of vaccine experts across 3 days of built-in 1-2-1 networking

⚠️ We do not collaborate with third parties for hotels, travel, data services, or event attendee lists. Please be cautious of phishing emails that misuse our logos, and refrain from engaging with any organisations outside of Terrapinn without consulting us first.

Launching in 2027 alongside WVC Europe

Following its global launch in the US alongside the World Vaccine Congress Washington in March 2027, the inaugural World BioSecurity Congress & Expo Europe will debut in October 2027, co-located with the World Vaccine Congress Europe in Lyon. This brand-new event brings together key stakeholders in biosecurity, biosafety, and medical countermeasures to strengthen global preparedness, threat awareness, and response.

The Start-to-Finish of Vaccines

From immune profiling & clinical development, to global health, supply, and access

Supply & Logistics
Learn how we are dealing with the supply demands and the technologies that will allow last mile delivery

New Technology
Innovations reshaping vaccine development and delivery

Cancer & Immunotherapy
Pioneering cancer vaccines and the future of immunotherapy combinations

Partnerships & Access
Secure funding, foster partnerships, and drive global market access

Pandemic Platforms
The most promising platforms that can be used for an outbreak, from pathogen adaptability to speed, scale up and implementation

Influenza & Respiratory
Cutting-edge developments in vaccines for respiratory diseases across all populations

Veterinary
Advancing veterinary vaccines and integrating the One Health approach to safeguard animal and public health

Global Health & Neglected Diseases
Advancing solutions for global health challenges and underserved diseases

Immune Profiling
Harness immune insights to design next-gen vaccines

Clinical Trials
Understand how to move your vaccine candidates through development phases to licensure

Working Groups
Interactive, discussion-driven sessions fostering collaboration and brainstorming among industry experts and participants

Emerging & Re-Emerging Diseases
Exploring innovative strategies and breakthroughs to combat emerging diseases and outbreak pathogens

Pre-Clinical Development
Optimising early-stage vaccine research and animal models

AMR & Bacterial Vaccines
Combating antimicrobial resistance through innovative bacterial vaccine solutions

Bioprocessing & Manufacturing
Meet with the manufacturers & bioprocessing experts to advance your vaccine formulation, tech transfer & scale-up

BioPharma Showcases
Explore the progress and innovations of biopharma companies advancing the next generation of vaccines and therapeutics

View Agenda

Apply To Speak

2026 Speakers

Marco Cavaleri
Head of Public Health Threats
European Medicines Agency

Charlotte Vernhes
Director Scientific and Medical Affairs
Vaccines Europe
Jerome Kim
Director General
IVI

Melanie Saville
Chief Scientific Officer
PATH
Maria Elena Bottazzi
Co-Director of Texas Children's Hospital Center for Vaccine Development
Baylor College of Medicine

Erick Lelouche
President
lyonbiopole
Raman Rao
Chief Executive Officer
Hilleman Laboratories Singapore Pte Ltd

Wolfgang Philipp
Principal Adviser for Health and Crisis Management, Directorate-General for Health and Food Safety (SANTE)
European Comission
Mark Jit
Chair and Professor, Department of Global and Environmental Health
new york university

Maarten Postma
Chair, Faculty of Economics & Business,
University of Groningen
Jeffrey Almond
Former VP Discovery R&D, Sanofi & Visiting Professor
University of Oxford

Andrew Deavin
Senior Director
GSK
Ankur Mutreja
Director of External Affairs and Health Security
South Asia-PATH

Jan Poolman
Executive Advisor & Founder
CreaBacVac B.V.
Jeremy Salt
Chief Executive Officer
The Vaccine Group

Joris Vandeputte
Past President
IABS
Michael Caldwell
Assoc VP Vaccine Research & Education
Meharry Medical College

Richard White
Professor of Infectious Disease Epidemiology
London School of Hygiene and Tropical Medicine
Luigi Buonaguro
Lab director
National Cancer Institute

Bassam Hallis
Head of Vaccine Development and Evaluation Centre
UK Health Security Agency
Darren Leneghan
Consultant, Life Sciences
Venture Valuation

Irina Meln
Head of Innovation
European Vaccine Initiative
Hanneke Schuitemaker
CSO
Valneva Austria GMBH

George Simeon
CEO
Curevo Vaccine
Nico Vandaele
Prof. dr.
KU Leuven, Access-To-Medicines Research Centre

Elissa R Weitzman
Associate Professor, Director of Research
Boston Children's Hospital, and Harvard Medical School
Mateusz Hasso-Agopsowicz
Technical Officer
World Health Organization

Ligia Pinto
Director, Vaccine, Immunity and Cancer Directorate
Frederick National Laboratory for Cancer Research
Holy Akwar
Science Advisor, Veterinary & AMR
International Centre for Antimicrobial Resistance Solutions (ICARS)

Tor Biering-Sørensen
Professor, Chief Physician, Faculty of Health and Medical Sciences, University of Copenhagen
Herlev and Gentofte Hospital
David Burkhart
CEO
Inimmune Corp

Lucy Chappell
Chief Scientific Adviser
UK Department of Health and Social Care
Rory De Vries
Associate Professor
Erasmus M.C.

Jonathan Hare
Translational Science Lead
The Francis Crick Institute
Jonathan Jones
Manager - Microbial Fermentation
CPI

Judith Kallenberg
Senior Director, Global Health Access
GSK
Ruben Rizzi
SVP Global Regulatory Affairs, Safety & Pharmacovigilance
BioNTech SE

Anja Schreijer
Medical Director Pandemic and Disaster Preparedness Center
Erasmus MC
Walter Straus
Vice President, Clinical Safety & Risk Management
Moderna Therapeutics

Roland Ventura
VFI Advisor
Vaccine Formulation Institute
Y. Tony Yang
Professor
The George Washington University

Paul-Henri Derrien
Industrial Director
France Biolead
Nigel Temperton
Professor
University of Kent

Tim Cooke
CEO
Omniose
Ofer Levy
Director, Precision Vaccines Program
Boston Children's Hospital

Nicola Lewis
Director of Worldwide Influenza Centre
The Francis Crick Institute
Alessandro Manenti
Chief Development Officer
VisMederi S.r.l.

Giovanna Riggall
Head of Global Heath Supply Chain
Unimed
Meta Roestenberg
CEO INFECTA
Leiden University Medical Center (Netherlands)

Kashmira Date
Medical
Pfizer
Karelle DE LUCA
Head of R&D
GALVmed

Teresa Lambe
Calleva Head of Vaccine Immunology & Professor of Vaccinology & Immunology
University of Oxford
Mariagrazia Pizza
Professor of Microbiology
Imperial College London

Miguel Prudencio
Group Leader
Gulbenkian Institute for Molecular Medicine
David Goldblatt
Professor of Vaccinology and Immunology and Director of Clinical Research and Development
UCL

Mats Lundgren
CSO
Abera Bioscience AB
Ab Osterhaus
Director of Research Center For Emerging Infections and Zoonoses and Professor
University of Veterinary Medicine Hannover

Morten Ruhwald
Chief Medical Officer
Novo Nordisk Foundation Initiative for Vaccines and Immunity
Robbert van der Most
CEO
Vaxxcellence

Richard Wyatt
Director Viral Immunology, IAVI Center for Neutralizing Antibodies
The Scripps Research Institute
Rebecca Fish
Professor, Director of Health Program at UNC Chapel Hill
Formerly Merck, GSK, US Senior Vaccine Advisor at HHS

Jeroen Kortekaas
Scientific Expert Infectious Diseases
Boehringer Ingelheim
Peter Marks
SVP Molecule Discovery and Head of Infectious Diseases
Eli lilly

Jinte Middeldorp
Department Head Neurobiology & Aging
Biomedical primate Research Centre
Mónica Perea-Vélez
CMC Advocacy and Policy Director
GSK

Nicholas Perombelon
Head of Vaccines and Therapies for Infectious Diseases
EMA
Paco Pino
VP R&D
ExcellGene

Dakshina Reddy
Head of Global Regulatory Strategy and Operations
Bill & Melinda Gates Medical Research Institute
Anna Saernefaelt
Global CMC Lead
CEPI

Georgios Stathopoulos
Technical Officer, Vaccine Access
World Health Organization
Keith Sumption
Former Chief Veterinary Officer
FAO

Maxime Taquet
Associate Professor
University of Oxford
Hamid Trimech
Head
ARCALIS, Inc.

Peter Tygesen
Business Development Director - Adjuvants
SPI Pharma
Sebastian Ulbert
Deputy Director
Fraunhofer-Institute for Cell Therapy and Immunology

Saul Walker
Director for Public Partnerships
CEPI
Gavin Wright
Chair of Microbial Biochemistry
University of York

Cristiana Campa
External Intelligence & Innovation Lead, DDS
GSK
Jelle Klein
Medical Director CPU
SGS Belgium NV.

Amita Vaidya
Associate Director
Sanofi
Hamilton Bennett
Global Health Security R&D and Partnerships
Moderna

Nele Steens
Head of R&D Division
FAGG
Thomas Waite
Deputy Chief Medical Officer
Department of Health and Social Care

Matthew Wilson
Chief Executive Officer & Founder
U-Med
Mats Welin
Senior Expert
Medical Products Agency Lakemedelsverket

Annaliesa Anderson
SVP & Chief Vaccines Officer
Pfizer
Rituparna Das
Therapeutic Area Head, Respiratory Vaccines
Moderna

Michel De Wilde
Former Senior Vice President R&D Of Sanofi Pasteur & Owner
MDW Consultant LLC
Lenny Moise
VP, Research
SeromYx

Karen O'Hanlon
Chief Development Officer
Stablepharma
Jerald Sadoff
Chief Medical Officer
Centivax

Tyler Sandberg
Product Manager
Mabtech
Clara Schoeder
Assistant Professor
University of Leipzig

Asimenia Angelidou
Assistant Professor of Pediatrics
Harvard Medical School
Christine Dahlke
Translational Immunology Lead
CEPI

Jonathan Heeney
Chief Scientific Officer
DIOSynVax
Marcus Lacey
Exec Director Global Pandemic
CSL Seqirus

Arianna Marini
Associate Director, Global Clinical Immunology
IAVI
Senthil Ranganathan
VP, Technical Development and CMC Operations
GeoVax Labs, Inc.

Delphine Saragoussi
Head of Pharmacoepidemiology, Vaccines, Patient Safety & Pharmacovigilance
Sanofi
Vanessa Vankerckhoven
CEO & Founder
IDEVAX

Elisa Rosati Scalchi
Scientific Lead
ImmuneSpec BV
Sibilia Quilici
Executive Director
Vaccines Europe

Nicola Rose
Executive Director Science and Research (NIBSC)
MHRA
Alexander Douglas
Associate Professor
University of Oxford

Emilie Karafillakis
European Director, Vaccine Confidence Project
London School of Hygiene and Tropical Medicine
Gemma Lahuerta
Head CDMO
LABORATORIO REIG JOFRE, S.A.

Niall Macaulay
Policy Officer
Health Emergency Preparedness and Response Authority
Ana Milinkovic
Global Regulatory Lead
GSK

Valentjin Schweitzer
Clinical Microbiologist and Epidemiologist
University of Utrecht
Elske Sieswerda
Clinical Microbiologist and Epidemiologist
Ecraid

Flavie Vial
Programme Officer vaccines
WOAH
Kim Bouwman
Scientist
Wageningen University

Ajoy Chakrabarti
Portfolio And Platform Lead
The Bill & Melinda Gates Foundation
Tim Fugmann
CSO and Co-founder
Alithea Bio

Danna Hargett
Head of Healthcare Strategy Practice
Alcimed
Stijn Hollemeersch
Medical Affairs Director
HIPRA

Ashraf Ibrahim
Founder and CEO
Vitalex Biosciences LLC
Heiko Keller
Supply Chain Manager
Center for Pandemic Vaccines and Therapeutics (ZEPAI) at Paul-Ehrlich-Institute (PEI)

Meghan Pennini
Director, Translational Science
Foundation for the National Institutes of Health
Blerina Shkodra
Chief Scientific Officer
leon-nanodrugs GmbH

Robert Walker
Executive Vice President, Head of R&D
Novavax
Adriana Bastidas
Head of Medical
P95 BV

Pascal Blanc
Senior Principal Scientist
Sanofi
Martinus Capelle
Distinguished Scientist II
Janssen

Emilie Danve-Chery
Global Project Head - Research Portfolio & Strategy Vaccines
Sanofi
Frédéric Debellut
Senior Health Economist
PATH

Maria Dutarte
Executive Director
EUPATI
Gonçalo Farias
Laboratory Manager, Nasal and Innovation Services
Aptar Pharma

Edward Grahame
BioPharma Services Alliance Manager
Cytiva
Holger Hannemann
Director of R&D, Antigens and Reagents
The Native Antigen Company

Karin Hardt
Director Clinical Development, Scientist
Johnson & Johnson Innovation
Sandy Kimber
Research Leader, Infection and In Vivo Pharmacology
IQVIA Laboratories

Ben Knappett
Sr. Product Manager, Sunny Suite
Unchained Labs
Paul LaBarre
SVP of Global Business Development
PharmaJet

Farzana Muhib
Program Advisor
PATH
Marta Murreddu
Business Development Director
cerba research

Hironori Nakagami, M.D. Ph.D.
Professor, Dept. of Health Development and Medicine
Osaka University
Julia Oswald
Senior Director Project Oversight, Respiratory, Infectious Diseases & Vaccines
PPD clinical Research business of Thermo Fisher Scientfic

Rolando Pajon
Chief Medical and Scientific Officer
BIOFABRI SLU
Anthony Pajot
Global Project Head
Sanofi Vaccines

Tarun Saluja
Director, Clinical Development
International Vaccine Institute
Cornelius Schmaltz
Strategic Science Adviser
European Commission, DG HERA

Callum Scott
Senior Vice President, Development
Scancell Ltd.
Thomas Trolle
Director, Bioinformatics & AI/ML
Evaxion Biotech

Eleanor Wilson
Executive Director
Moderna
Chung-Yi Wu
CEO
CHO PHARMA INC.

Tony Fonk
CEO
SpotSee
Sanna Mesman
Veterinary Policy Officer
European Comission

Adam Poulsen
Pharma Specialist
Sani Membranes
Yuta Kunishima
Researcher
BIKEN

Kazumi Noguchi
Assistant Manager
BIKEN
Joe Keenan
Director of Regulatory & Commercial Strategy
Daicel

Cedric Bogaert
Chief Executive Officer
myNEO Therapeutics
Juliana Cassataro
Professor
University of San Martin

Pär Comstedt
VP Infectious Disease Vaccine Development
Evaxion Biotech A/S
Benjamin DAMIEN
CEO
Sagitta Biotech

Joanne Marie Del Rosario
Team Leader - Antigen Payload Development
DIOSynVax Limited
Chirstopher Green
Professor and Consultant Physician in Infectious Diseases & Global Health
University of Birmingham

Swati Gupta
Former VP of Head of Emerging Infectious Diseases and Epidemiology, IAVI
Fulcrum Health
Clarissa Koch
Chief Scientific Officer
Leyden Labs

Hans Langedijk
Co-founder
ForgeBio
Carol Leung
Group Leader
University of Oxford

Amelia Mosley
Sr. Director of R&D Partnerships
IAVI
Scott Ratzan
Editor-in-Chief
Cuny School of Public Health

Andrew Van Kessel
Director of Research
Vaccine and Infectious Disease Organization
Laura Viviani
Consultant
SciEthiQ

Amanda Williams
Chief Executive
ISRV
Minmin Yen
CEO & Co-Founder
PhagePro, P.B.C.

Luisa Amoedo
VP Operations Recipharm Advance Bio
Recipharm
Louis Ates
Associate director - Infectious Disease Vaccines
BioNTech

Lajos Bognar
Subregional Representative, Brussels
WOAH
Nnenna Chime
Head Global Clinical Franchise - Vaccines
Sanofi

Dennis Christensen
Head of Global R&D
Croda Pharma
Madhavsai Gajjar
Field Applications Scientist
Thermo Fisher

Juleen Gayed
Clinical Development Medical Director
Pfizer
Paul Gillard
Vice President, Medical Science & Strategy
PPD clinical research business of ThermoFisher Scientific

Joshua Hunt
Head of Agile Delivery
Digital Health and Care Wales
Fran Priddy
Executive Director, Clinical Development
Moderna

Frank Theobald
Vice President, Head MAP Program
LTS Lohmann Therapie-Systeme AG
Ola Tuvesson
CTO
NorthX Biologics

Francois Beckers
Head Global Biostatistical Sciences
Sanofi
Wian de Jongh
CEO
adaptvac

Elissandro KLEIN
R&D Project Manager
Biotech One
Puck Pelzer
Associate director
IAVI

Mihai Bilanin
Global Regulatory Lead
GSK
Ben Carmel
Chief Revenue Officer
Slope Clinical

Ghania Chikh
Senior Director, Vaccine Development
Acuitas Therapeutics, Inc.
Gregory Glenn
CEO
Pinion Immunotherapeutics

Michael Graz
Interim Chief Scientific Officer
Innoture
Juhienah Khalaf
Director of Chemistry
Inimmune Corporation

Sergey Konstantinov
Senior Researcher
Erasmus MC
Calman MacLennan
Professor
Imperial College London

Matilu Mwau
Senior Principal Clinical Research Scientist, Professor of Infectious Diseases
Kenya Medical Research Institute(KEMRI)
Ellery Nadarajah
Chief of Staff
Delfa

Thomas Robert
Senior Innovation & Scientific Affairs Lead
Univercells Technologies
Jo Walton
Member of Supervisory Board
Access to Medicine Foundation

Ndadilnasiya Endie Waziri
Immunization and PHC Advisor
African Field Epidemiology Network (AFENET)
Jose Lagaron
Founder / CSO
BIONANOPHARMA

Busisiwe Mbali Mpila
Regional Director, Business Development (Africa, EU, APAC)
DFnet
Erhard van der Vries
Chief Scientific Officer
Cores

Melanie Carr
Deputy Executive Director and Head of Stakeholders and Communications
European Medicines Agency
Olivier Collignon
Senior Biostatistician
European Medicines Agency

Ingrid de Visser-Kamerling
Research Director
Stichting Centre for Human Drug Research
Aslan Dehghani
Manager of Nanoparticle Technologies
Sartorius Lab Instruments GmbH & Co. KG

Mathias Kahl
Head of Development
IDT Biologika GmbH
Amin Khan
Chief Science Advisor
Afrigen Biologics and Vaccines

Thomas Lake
Chief Business Officer
Vaxxas
Alex Mann
Senior Director Clinical Science
Hvivo

Laura Cornelissen
Team lead VPD - Epidemiology of Infectious Diseases
Sciensano
Birgitte Giersing
Unit Head, Vaccine Research, Development and Policy, Department of Immunization, Vaccines and Biologicals
World Health Organisation (WHO)

Mendel Haag
Sr. Director
CSL Seqirus
Esther Heijnen
VP Head of Development
Seqirus

Adrian Hill
Director and Professor
The Jenner Institute - University of Oxford
Tim Hirst
CEO
GPN Vaccines Ltd

Kevin Mugenyi
Senior Epidemiologist
African Field Epidemiology Network (AFENET)
Angelo Raggioli
Head of Vectorology
ReiThera

ALN Reddy
Sr Vice President
Biological E Limited
Thomas Sorensen
Chief
UNICEF

Saranya Sridhar
VP Head of Clinical Development
Sanofi
Yong Zu
Business Development
Genevoyager Co. Ltd.

Joe Smyser
Chief Executive Officer
PGP (The Public Good Projects)
Eline Van Der Hoek
Managing Director
InFECT-NL

Peter Weinstein
Chief Executive officer
Vaxxirna
Richard Welch
VP BioProcess Develpment and Manufacturing
IAVI

Arpit Agarwal
Director, Medical Affairs
VaxTRIALS Part of Emmes Group
Maria Alriksson
CEO
Abera Bioscience AB

Kwasi Amfo
Founder and CEO
Luipaard
Yavuz Çelik
Product Manager
Hamilton AG

Scott Deeter
CEO
InVitria
Luc Gagnon
Global Head Vaccine Sciences
IQVIA Laboratories

Vanessa Landtwing
Partner
McKinsey & Company
Rosa Poetes
Partner
McKinsey & Company

Sushant Sahastrabuddhe
Associate Director General
International Vaccine Institute
Mads Skovvang
Europe Product Manager, Commercial Supply Chain
Cencora/ World Courier

Amina Cherif Louazani
Viral Safety and Regulatory Affairs Manager
PathoQuest SAS
Marco Goeijenbier
Internal Medicine & Intensive care
Erasmus MC

Jason He
Head of WuXi Vaccines Business Development and CMC Management
WuXi Vaccines
Ysaline Roland
Head of Bioprocess Department
NAOBIOS

Pieter Jan Vos
CEO
VirXcel B.V.
Sina Bavari
Executive Vice President, Infectious Disease Research and Development
Tonix

Basiel Cole
Project Leader, Senior Scientist
Ziphius Vaccines
Nina Malkevich
Senior Director and Product Development Lead
International AIDS vaccine initiative

Patrick Mboya Nguku
Regional Coordinator
AFENET
Farooq Nasar
Director, Virology, Research and Development Center
Tonix Pharma

Saheed Oluwatoyin Gidado
National Coordinator, NSTOP Nigeria
African Field Epidemiology Network (AFENET)
Mark Sumeray
CMO
Virometix AG

Gabriella Worwa
Study Director
Tonix Pharmaceuticals
Ilena Boemi
Portfolio Manager
Frontiers Media SA

Caroline De Melo
Postdoctoral researcher
Amsterdam UMC
Nayeli Esparza
postdoctoral fellew
Université Laval

Paulina Franceschi
Director
Centro Regional de Innovación en Vacunas y Biofármacos (CRIVB AIP)
Suvi Haimi
CEO / Co-Founder
Velocin

Adam Kucharski
Professor & Co-founder, Wholesum
London School of Hygiene and Tropical Medicine
Prabudddha Kundu
Co-founder and Managing Director
Premas BIotech Private Limited

Vega Masignani
Alliance Director
CARB-X
Katharina Mühlhoff
Researcher
Heidelberg Institute of Global Health

Emmanuel Hanon
Chair, Scientific Advisory Board
Astrivax

APPLY TO SPEAK

VIEW PROSPECTUS

APPLY TO SPONSOR / EXHIBIT

World Vaccine Congress Europe 2023 Testimonials

“It was very well organised; the size was
perfect for effective networking, and the
sessions were interesting.”

- Head of Innovation, European Vaccine Initiative

“Highly professional organisation. Every
minute detail is kept in mind. An excellent set of speakers from all over the world, with latest topics addressed by subject matter experts.”

- CEO, DCVMN

“The World Vaccine Congress Europe is an essential annual milestone for anyone committed to the future of vaccine science. It brings together the most brilliant minds and innovative leaders shaping global health. The level of professionalism, scientific depth and global collaboration is unmatched.”

- Michael Caldwell, Associate Vice President, Vaccine Research & Education, Meharry Medical College

R&D + Strategic Partnering For The
Global Vaccine Industry

Europe's Largest Vaccine Event

2,000+

280

150+

3

2,000+

18,000+

Launching in 2027 alongside WVC Europe

The Start-to-Finish of Vaccines

From immune profiling & clinical development, to global health, supply, and access

2026 Speakers

2026 Sponsors and Exhibitors

Get involved at World Vaccine Congress Europe 2027

TO SPONSOR

Christian Larsmon
Christian.Larsmon@terrapinn.com

TO SPEAK

Isla Sutherland
Isla.Sutherland@terrapinn.com

MARKETING & PRESS

Jasper Cameron
Jasper.Cameron@terrapinn.com

Stay up-to-date

Created by

R&D + Strategic Partnering For The Global Vaccine Industry

Europe's Largest Vaccine Event

2,000+

280

150+

3

2,000+

18,000+

Launching in 2027 alongside WVC Europe

The Start-to-Finish of Vaccines

From immune profiling & clinical development, to global health, supply, and access

2026 Speakers

2026 Sponsors and Exhibitors

Get involved at World Vaccine Congress Europe 2027

TO SPONSOR

Christian Larsmon Christian.Larsmon@terrapinn.com

TO SPEAK

Isla Sutherland Isla.Sutherland@terrapinn.com

MARKETING & PRESS

Jasper Cameron Jasper.Cameron@terrapinn.com

Stay up-to-date

Created by

R&D + Strategic Partnering For The
Global Vaccine Industry

Christian Larsmon
Christian.Larsmon@terrapinn.com

Isla Sutherland
Isla.Sutherland@terrapinn.com

Jasper Cameron
Jasper.Cameron@terrapinn.com